Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Acta Cirúrgica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502017000900712 |
Resumo: | Abstract Purpose: To investigate the participation of cysteinyl leukotrienes in the pathophysiology of oral mucositis. Methods: Oral mucositis was induced in hamsters using 5-fluorouracil (5-FU; 60 and 40 mg/kg; i.p., on days 1 and 2, respectively, and with excoriations in jugal mucosa on day 4). Montelukast (10, 20, or 40 mg/kg/d; gavage), MK886 (3 mg/kg/d, i.p.), or saline or celecoxib (7.5 mg/kg/d; i.p.) was administered 1 h prior to 5-FU and daily, until the fourth (MK886) or tenth day, when the animals were euthanized and their jugal mucosa was collected for macroscopic, histopathological, and immunohistochemical evaluation. Results: Neither montelukast nor MK-886 prevented the oral mucositis induced by 5-FU, as observed by histopathological evaluation. In addition, we did not find significant differences in the expression of inducible nitric oxide synthase-2, cyclooxygenase-2, or interleukin (IL)-1β between the experimental and control groups. However, we did observe a significant decrease in tumor necrosis factor (TNF)-α expression for all doses of montelukast; we also observed a significant decrease in IL-10 with 40 mg/kg/d and MK 886. Conclusions: Cysteinyl leukotrienes do not play an important role in experimental oral mucositis induced by 5-FU. There is a modulating action specifically on TNF-α. |
id |
SBDPC-1_df973e309f2160c0257958e67969ad65 |
---|---|
oai_identifier_str |
oai:scielo:S0102-86502017000900712 |
network_acronym_str |
SBDPC-1 |
network_name_str |
Acta Cirúrgica Brasileira (Online) |
repository_id_str |
|
spelling |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracilArachidonate 5-LipoxygenaseStomatitisFluorouracilCricetinaeAbstract Purpose: To investigate the participation of cysteinyl leukotrienes in the pathophysiology of oral mucositis. Methods: Oral mucositis was induced in hamsters using 5-fluorouracil (5-FU; 60 and 40 mg/kg; i.p., on days 1 and 2, respectively, and with excoriations in jugal mucosa on day 4). Montelukast (10, 20, or 40 mg/kg/d; gavage), MK886 (3 mg/kg/d, i.p.), or saline or celecoxib (7.5 mg/kg/d; i.p.) was administered 1 h prior to 5-FU and daily, until the fourth (MK886) or tenth day, when the animals were euthanized and their jugal mucosa was collected for macroscopic, histopathological, and immunohistochemical evaluation. Results: Neither montelukast nor MK-886 prevented the oral mucositis induced by 5-FU, as observed by histopathological evaluation. In addition, we did not find significant differences in the expression of inducible nitric oxide synthase-2, cyclooxygenase-2, or interleukin (IL)-1β between the experimental and control groups. However, we did observe a significant decrease in tumor necrosis factor (TNF)-α expression for all doses of montelukast; we also observed a significant decrease in IL-10 with 40 mg/kg/d and MK 886. Conclusions: Cysteinyl leukotrienes do not play an important role in experimental oral mucositis induced by 5-FU. There is a modulating action specifically on TNF-α.Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia2017-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502017000900712Acta Cirúrgica Brasileira v.32 n.9 2017reponame:Acta Cirúrgica Brasileira (Online)instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)instacron:SBDPC10.1590/s0102-865020170090000004info:eu-repo/semantics/openAccessSilva,Viviane Carvalho daLeitão,Renata Ferreira de CarvalhoBrito,Gerly Anne de CastroMartins,Conceição da SilvaFreire,Gildenio EstevamAragão,Karoline SaboiaWanderley,Carlos Wagner de SouzaFreitas,Marcos Rabelo deeng2018-04-09T00:00:00Zoai:scielo:S0102-86502017000900712Revistahttps://www.bvs-vet.org.br/vetindex/periodicos/acta-cirurgica-brasileira/https://old.scielo.br/oai/scielo-oai.php||sgolden@terra.com.br0102-86501678-2674opendoar:2018-04-09T00:00Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)false |
dc.title.none.fl_str_mv |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil |
title |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil |
spellingShingle |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil Silva,Viviane Carvalho da Arachidonate 5-Lipoxygenase Stomatitis Fluorouracil Cricetinae |
title_short |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil |
title_full |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil |
title_fullStr |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil |
title_full_unstemmed |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil |
title_sort |
Role of the route of leukotrienes in an experimental model of oral mucositis induced by 5-fluorouracil |
author |
Silva,Viviane Carvalho da |
author_facet |
Silva,Viviane Carvalho da Leitão,Renata Ferreira de Carvalho Brito,Gerly Anne de Castro Martins,Conceição da Silva Freire,Gildenio Estevam Aragão,Karoline Saboia Wanderley,Carlos Wagner de Souza Freitas,Marcos Rabelo de |
author_role |
author |
author2 |
Leitão,Renata Ferreira de Carvalho Brito,Gerly Anne de Castro Martins,Conceição da Silva Freire,Gildenio Estevam Aragão,Karoline Saboia Wanderley,Carlos Wagner de Souza Freitas,Marcos Rabelo de |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Silva,Viviane Carvalho da Leitão,Renata Ferreira de Carvalho Brito,Gerly Anne de Castro Martins,Conceição da Silva Freire,Gildenio Estevam Aragão,Karoline Saboia Wanderley,Carlos Wagner de Souza Freitas,Marcos Rabelo de |
dc.subject.por.fl_str_mv |
Arachidonate 5-Lipoxygenase Stomatitis Fluorouracil Cricetinae |
topic |
Arachidonate 5-Lipoxygenase Stomatitis Fluorouracil Cricetinae |
description |
Abstract Purpose: To investigate the participation of cysteinyl leukotrienes in the pathophysiology of oral mucositis. Methods: Oral mucositis was induced in hamsters using 5-fluorouracil (5-FU; 60 and 40 mg/kg; i.p., on days 1 and 2, respectively, and with excoriations in jugal mucosa on day 4). Montelukast (10, 20, or 40 mg/kg/d; gavage), MK886 (3 mg/kg/d, i.p.), or saline or celecoxib (7.5 mg/kg/d; i.p.) was administered 1 h prior to 5-FU and daily, until the fourth (MK886) or tenth day, when the animals were euthanized and their jugal mucosa was collected for macroscopic, histopathological, and immunohistochemical evaluation. Results: Neither montelukast nor MK-886 prevented the oral mucositis induced by 5-FU, as observed by histopathological evaluation. In addition, we did not find significant differences in the expression of inducible nitric oxide synthase-2, cyclooxygenase-2, or interleukin (IL)-1β between the experimental and control groups. However, we did observe a significant decrease in tumor necrosis factor (TNF)-α expression for all doses of montelukast; we also observed a significant decrease in IL-10 with 40 mg/kg/d and MK 886. Conclusions: Cysteinyl leukotrienes do not play an important role in experimental oral mucositis induced by 5-FU. There is a modulating action specifically on TNF-α. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-09-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502017000900712 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502017000900712 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/s0102-865020170090000004 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia |
publisher.none.fl_str_mv |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia |
dc.source.none.fl_str_mv |
Acta Cirúrgica Brasileira v.32 n.9 2017 reponame:Acta Cirúrgica Brasileira (Online) instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC) instacron:SBDPC |
instname_str |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC) |
instacron_str |
SBDPC |
institution |
SBDPC |
reponame_str |
Acta Cirúrgica Brasileira (Online) |
collection |
Acta Cirúrgica Brasileira (Online) |
repository.name.fl_str_mv |
Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC) |
repository.mail.fl_str_mv |
||sgolden@terra.com.br |
_version_ |
1752126444495962112 |